Changes in bone and lipid metabolism in postmenopausal women with early breast cancer after terminating 2-year treatment with exemestane: a randomised, placebo-controlled study.

Geisler, J; Lønning, P E; Krag, L E; Løkkevik, E; Risberg, T; Hagen, A I; Schlichting, E; Lien, E A; Ofjord, E S; Eide, G E; Polli, A; di Salle, E; Paolini, J

Geisler, J; Lønning, P E; Krag, L E; Løkkevik, E; Risberg, T; Hagen, A I; Schlichting, E; Lien, E A; Ofjord, E S; Eide, G E; Polli, A; di Salle, E; Paolini, J.

Affiliation

Geisler J; Section of Oncology, Department of Medicine, Haukeland University Hospital, University of Bergen, NO-5021, Bergen, Norway.

Eur J Cancer ; 42(17): 2968-75, 2006 Nov.

Article in En | MEDLINE | ID: mdl-16963261

Subject(s)

Search on Google

Add to My VHL

XML

PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: Breast Neoplasms / Bone Density / Aromatase Inhibitors / Androstadienes Type of study: Clinical_trials / Observational_studies / Prognostic_studies Limits: Female / Humans / Middle aged Language: En Journal: Eur J Cancer Year: 2006 Document type: Article Affiliation country: Country of publication:

Search on Google

Add to My VHL

XML

PubMed Links